9.925

0.45% -0.045

After Hours: 9.95 0.025 +0.25%

Immucell Corp (ICCC)

Overview News Price History Financials Discussions Forecast Stock Split

Immucell Corp stock is traded at $9.925, with a volume of 5,050. It is down -0.45% in the last 24 hours and up +0.86% over the past month. ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Previous Close:

$9.97

Open:

$9.96

24h Volume:

5,050

Relative Volume:

0.19

Market Cap:

$90.14M

Revenue:

$29.93M

Net Income/Loss:

$-545.30K

P/E Ratio:

-164.87

EPS:

-0.0602

Net Cash Flow:

$3.38M

1W Performance:

-0.25%

1M Performance:

+0.86%

6M Performance:

+54.11%

1Y Performance:

+64.19%

1-Day Range:

$9.6701

$9.96

1-Week Range:

$9.6701

$10.16

52-Week Range:

$4.52

$12.10

Immucell Corp Stock (ICCC) Company Profile

Name

Immucell Corp

Sector

Healthcare (1067)

Industry

Biotechnology (595)

Phone

(207) 878-2770

Address

56 EVERGREEN DR, PORTLAND, ME

Employee

Twitter

Next Earnings Date

2026-11-12

Latest SEC Filings

ICCC's Discussions on Twitter

Compare ICCC vs VRTX, REGN, MRNA, ARGX, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ICCC Immucell Corp	9.925	90.14M	29.93M	-545.30K	3.38M	-0.0602
VRTX Vertex Pharmaceuticals Inc	526.19	133.37B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	788.04	81.13B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	198.88	79.40B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	959.49	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	204.97	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Immucell Corp Stock (ICCC) Latest News

Sep 22, 2026

ICCC Price Today: Immucell Corp. Stock Price, Quote & Chart | MEXC - mexc.co

Sep 22, 2026

Sep 18, 2026

Immucell Stock Price Forecast. Should You Buy ICCC? - StockInvest.us

Sep 18, 2026

Aug 27, 2026

ImmuCell Stock Falls 8.8% Despite Y/Y Earnings & Sales Growth in Q2 - Yahoo Finance

Aug 27, 2026

Aug 24, 2026

ICCC | Immucell Corp FinancialsRevenue Breakdown - Quiver Quantitative

Aug 24, 2026

Aug 20, 2026

ImmuCell (ICCC) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 20, 2026

Aug 14, 2026

ImmuCell CorporationCommon Stock (ICCC) Stock Price, News, Quote & History - FinancialContent

Aug 14, 2026

ImmuCell Q2 2026 slides: revenue gains offset by margin pressure - Investing.com

Aug 14, 2026

ImmuCell Q2 Earnings Call Highlights - MarketBeat

Aug 14, 2026

Earnings call transcript: ImmuCell posts strong Q2 2026 sales growth, shares fall - Investing.com

Aug 14, 2026

ImmuCell Corporation Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 14, 2026

Aug 13, 2026

ImmuCell (NASDAQ:ICCC) Announces Earnings Results, Beats Estimates By $0.15 EPS - MarketBeat

Aug 13, 2026

IMMUCELL CORP /DE/ Q2 2026: Revenue $7.19M, EPS $0.2— 10-Q Summary - TradingView

Aug 13, 2026

ImmuCell Corporation (ICCC) doubles profit on higher First Defense sales - Stock Titan

Aug 13, 2026

ImmuCell Plans About $4.5M Expansion for Calf Health Products - Stock Titan

Aug 13, 2026

Aug 11, 2026